To more closely explore the essential of targets CRAF and MEK1/2 to erianin, we tested efficiency of erianin after knockdown of CRAF and MEK1/2 by transfecting shRNA into cancer cell lines (Fig. 4a). This evidence concerns the gene MAP2K1 and cancer.